NIAID Banner Logo Image

ONLINE DATABASE SEARCH - HIV-LS-342-MEMO

1. 48482 HIV-LS-342; PUBMED-HIV-2/21/2006

Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P(2)(')-ligands

Ghosh, AK, Schiltz, G, Perali, RS, Leshchenko, S, Kay, S, Walters, DE, Koh, Y, Maeda, K, and Mitsuya, H

Bioorg Med Chem Lett 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16480871&dopt=abstract


2. 48483 HIV-LS-342; PUBMED-HIV-2/21/2006

Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I

He, Y, Jiang, T, Kuhen, KL, Wolff, K, Yin, H, Bieza, K, Caldwell, J, Bursulaya, B, and Wu, TY

Bioorg Med Chem Lett 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16480865&dopt=abstract


3. 48484 HIV-LS-342; PUBMED-HIV-2/21/2006

Effectiveness of Nonpeptide Clinical Inhibitor TMC-114 on HIV-1 Protease with Highly Drug Resistant Mutations D30N, I50V, and L90M

Kovalevsky, AY, Tie, Y, Liu, F, Boross, PI, Wang, YF, Leshchenko, S, Ghosh, AK, Harrison, RW, and Weber, IT

J Med Chem 2006. 49(4): 1379-1387


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16480273&dopt=abstract


4. 48485 HIV-LS-342; PUBMED-HIV-2/21/2006

Structural and molecular interactions of CCR5 inhibitors with CCR5

Maeda, K, Das, D, Ogata-Aoki, H, Nakata, H, Miyakawa, T, Tojo, Y, Norman, R, Takaoka, Y, Ding, J, Arnold, E, and Mitsuya, H

J Biol Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16476734&dopt=abstract


5. 48486 HIV-LS-342; PUBMED-HIV-2/21/2006

The Level of Reverse Transcriptase (RT) in Human Immunodeficiency Virus Type 1 Particles Affects Susceptibility to Nonnucleoside RT Inhibitors but Not to Lamivudine

Ambrose, Z, Julias, JG, Boyer, PL, Kewalramani, VN, and Hughes, SH

J Virol 2006. 80(5): 2578-81


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16474164&dopt=abstract



6. 48487 HIV-LS-342; PUBMED-HIV-2/21/2006

In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor

Sato, A, Hammond, J, Alexander, TN, Graham, JP, Binford, S, Sugita, KI, Sugimoto, H, Fujiwara, T, and Patick, AK

Antiviral Res 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16472877&dopt=abstract


7. 48488 HIV-LS-342; PUBMED-HIV-2/21/2006

Experimental/theoretical electrostatic properties of a styrylquinoline-type HIV-1 integrase inhibitor and its progenitors

Firley, D, Courcot, B, Gillet, JM, Fraisse, B, Zouhiri, F, Desmaele, D, d'Angelo, J, and Ghermani, NE

J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 2006. 110(1): 537-47


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16471566&dopt=abstract


8. 48489 HIV-LS-342; PUBMED-HIV-2/21/2006

HIV entry inhibitors: mechanisms of action and resistance pathways

Briz, V, Poveda, E, and Soriano, V

J Antimicrob Chemother 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16464888&dopt=abstract


9. 48490 HIV-LS-342; PUBMED-HIV-2/21/2006

Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2

He, Y, Jiang, T, Kuhen, KL, Wolff, K, Yin, H, Bieza, K, Caldwell, J, Bursulaya, B, Tuntland, T, Zhang, K, and Karanewsky, D

Bioorg Med Chem Lett 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16464578&dopt=abstract


10. 48491 HIV-LS-342; PUBMED-HIV-2/21/2006

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385

Miller, JF, Andrews, CW, Brieger, M, Furfine, ES, Hale, MR, Hanlon, MH, Hazen, RJ, Kaldor, I, McLean, EW, Reynolds, D, Sammond, DM, Spaltenstein, A, Tung, R, Turner, EM, Xu, RX, and Sherrill, RG

Bioorg Med Chem Lett 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16458505&dopt=abstract



11. 48492 HIV-LS-342; PUBMED-HIV-2/21/2006

A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection

Lund, N, Branch, DR, Mylvaganam, M, Chark, D, Ma, XZ, Sakac, D, Binnington, B, Fantini, J, Puri, A, Blumenthal, R, and Lingwood, CA

AIDS 2006. 20 (3): 333-343


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16439866&dopt=abstract


12. 48493 HIV-LS-342; PUBMED-HIV-2/21/2006

beta-Diketo acids with purine nucleobase scaffolds: Novel, selective inhibitors of the strand transfer step of HIV integrase

Nair, V, Uchil, V, and Neamati, N

Bioorg Med Chem Lett 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16439124&dopt=abstract


13. 48494 HIV-LS-342; PUBMED-HIV-2/21/2006

Pyridine N-oxide derivatives inhibit viral transactivation by interfering with NF-kappaB binding

Stevens, M, Pannecouque, C, De Clercq, E, and Balzarini, J

Biochem Pharmacol 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16438940&dopt=abstract


14. 48495 HIV-LS-342; PUBMED-HIV-2/21/2006

Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor

Victoriano, AF, Asamitsu, K, Hibi, Y, Imai, K, Barzaga, NG, and Okamoto, T

Antimicrob Agents Chemother 2006. 50(2): 547-55


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16436709&dopt=abstract


15. 48496 HIV-LS-342; PUBMED-HIV-2/21/2006

Dawn of non-nucleoside inhibitor-based anti-HIV microbicides

D'Cruz, OJ and Uckun, FM

J Antimicrob Chemother 2006. 57(3): 411-23


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16431862&dopt=abstract



16. 48497 HIV-LS-342; PUBMED-HIV-2/21/2006

Structure-Based QSAR Analysis of a Set of 4-Hydroxy-5,6-dihydropyrones as Inhibitors of HIV-1 Protease: An Application of the Receptor-Dependent (RD) 4D-QSAR Formalism

Santos-Filho, OA and Hopfinger, AJ

J Chem Inf Model 2006. 46(1): 345-54


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16426069&dopt=abstract


17. 48498 HIV-LS-342; PUBMED-HIV-2/21/2006

A Multivariate Analysis of HIV-1 Protease Inhibitors and Resistance Induced by Mutation

Almerico, AM, Tutone, M, Lauria, A, Diana, P, Barraja, P, Montalbano, A, Cirrincione, G, and Dattolo, G

J Chem Inf Model 2006. 46(1): 168-79


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16426053&dopt=abstract


18. 48499 HIV-LS-342; WOS-HIV-2/12/2006

Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro

Curr, K, Tripathi, S, Lennerstrand, J, Larder, BA, and Prasad, VR

JOURNAL OF GENERAL VIROLOGY 2006. 87: 419-428, 10


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234906800021


19. 48500 HIV-LS-342; WOS-HIV-2/12/2006

Concentricolide, an anti-HIV agent from the ascomycete Daldinia concentrica

Qin, XD, Dong, ZJ, Liu, JK, Yang, LM, Wang, RR, Zheng, YT, Lu, Y, Wu, YS, and Zheng, QT

HELVETICA CHIMICA ACTA 2006. 89(1): 127-133, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234988100014


20. 48501 HIV-LS-342; WOS-HIV-2/12/2006

Preliminary mapping of a putative inhibitor-binding pocket for human immunodeficiency virus type 1 integrase inhibitors

Lee, DJ and Robinson, WE

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2006. 50(1): 134-142, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234988000017


21. 48502 HIV-LS-342; WOS-HIV-2/19/2006

Integrase HIV-1: inhibition of catalytic activity by modified oligonucleotides

Prikazchikova, T, Mouscadet, JF, and Gottikh, M

FEBS JOURNAL 2005. 272: 17-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234826100056



22. 48503 HIV-LS-342; WOS-HIV-2/19/2006

Synthesis and in vitro evaluation of some novel benzofuran derivatives as potential anti-HIVI-1, anticancer, and antimicrobial agents

Rida, SM, El-Hawash, SAM, Fahmy, HTY, Hazza, AA, and El-Meligy, MMM

ARCHIVES OF PHARMACAL RESEARCH 2006. 29(1): 16-25, 10


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235121200002


23. 48504 HIV-LS-342; WOS-HIV-2/19/2006

Purification of a laccase from fruiting bodies of the mushroom Pleurotus eryngii

Wang, HX and Ng, TB

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY 2006. 69(5): 521-525, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235059000007


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021